BY Grace Zigah
A visiting delegation from the United Kingdom’s Parliament has commended Ghana’s significant contributions to global health research, following a tour of the Noguchi Memorial Institute for Medical Research (NMIMR) in Accra.
The high-profile visit formed part of efforts to strengthen bilateral cooperation in tackling major public health threats, including malaria, COVID-19, and emerging infectious diseases.
During their engagement, the MPs were briefed on the cutting-edge work in disease control and surveillance. Researchers at Noguchi showcased pioneering malaria control strategies, advanced COVID-19 testing capabilities, and robust systems for monitoring infectious disease outbreaks.
The delegation was particularly impressed by the institute’s integration of innovation, technology, and community-based approaches to public health.
In discussions with Ghanaian health scientists, the UK lawmakers emphasised that the future of global health security depends on partnerships based on mutual respect and knowledge exchange, rather than a one-sided model of aid.
They pledged to advocate for policies that will deepen Ghana–UK cooperation in medical research, capacity building, and resource mobilisation.
A key focus of the talks was the fight against malaria, which remains a major public health concern in sub-Saharan Africa despite decades of progress.
The delegation and Ghanaian experts jointly called for urgent international action to safeguard existing gains, secure sustainable funding, and accelerate efforts towards global malaria eradication.
The Noguchi Institute, established in 1979 as a joint Ghana–Japan initiative, has long been a hub for world-class biomedical research in West Africa.
Over the years, it has played a critical role in responding to health emergencies, from the Ebola preparedness efforts in 2014 to the COVID-19 pandemic, during which it became one of the main testing centres in Ghana.
Both sides agreed that the lessons from past collaborations — especially during COVID-19 — must inform future strategies to strengthen health systems, enhance disease surveillance, and ensure preparedness for future pandemics.
